Skip to main content
. 2018 Feb 19;41(1):154–166. doi: 10.1590/1678-4685-GMB-2017-0091

Table 3. Results related to splenic phagocytosis evaluation.

Experimental groups Phagocytosis
Absolute values Mean ± SE
LOT 1
NC 221 44.2 ± 0.66
IR-01 12 mg/kg 228 45.6 ± 1.77ª
IR-01 24 mg/kg 316 63.2 ± 1.28ª*
IR-01 48 mg/kg 369 73.8 ± 1.15ª*
LOT 2
DOX 670 134.0 ± 1.37ª*
+IR-01 12 mg/kg 321 64.2 ± 1.59b*
+IR-01 24 mg/kg 405 81.0 ± 1.30b*
+IR-01 48 mg/kg 373 74.6 ± 1.43b*
LOT 3
CIS 269 53.8 ± 1.35ª*
+IR-01 12 mg/kg 106 21.2 ± 1.35c*
+IR-01 24 mg/kg 74 14.8 ± 1.02c*
+IR-0148 mg/kg 54 10.8 ± 0.86c*
LOT 4
CPP 515 103.0 ± 2.00ª*
+IR-01 12 mg/kg 275 55.0 ± 3.46d*
+IR-01 24 mg/kg 316 63.2 ± 2.57d*
+IR-01 48 mg/kg 534 106.8 ± 3.13d

SE: Standard error of the mean; NC: Negative control group; DOX: Doxorubicin group; CIS: Cisplatin group; CPP: Cyclophosphamide group. (a)Statistically compared to the NC group; (b)Statistically compared to the DOX group; (c)Statistically compared to the CIS group; (d)Statistically compared to the CPP group; *statistically different (p < 0.05; Student’s t-test).